Mometasone Furoate Glenmark Pharmaceuticals Europe (Mometasone Furoate)

The drug binds to glucocorticoid receptors in skin cells, altering gene expression to suppress pro‑inflammatory cytokines, inhibit leukocyte migration and stabilise cell membranes. This results in strong anti‑inflammatory and immunosuppressive activity at the site of application.

The appropriate dose and frequency are determined by the prescribing healthcare professional based on the specific condition, severity, patient age and treatment area. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for topical Mometasone Furoate in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometasone Furoate is a high‑potency corticosteroid, offering stronger anti‑inflammatory effects than low‑potency agents such as hydrocortisone. Compared with other high‑potency steroids like clobetasol, it provides similar efficacy but may have a slightly different safety profile, making it suitable for short‑term use on sensitive areas.

Store the product at temperatures below 25 °C in its original packaging. Keep it away from moisture, direct sunlight and heat sources to maintain stability and potency.

Apply a thin layer of the cream, ointment or lotion to the affected skin area as directed by the prescriber. Gently rub it in until fully absorbed, and wash hands after application unless treating the hands themselves.

Serious risks include skin atrophy, telangiectasia, secondary infections and, with extensive or prolonged use, systemic corticosteroid effects such as adrenal suppression. Patients should report any unusual skin changes or systemic symptoms to their healthcare provider promptly.

Individuals with known hypersensitivity to mometasone furoate or any formulation excipients should avoid its use. It is also contraindicated on untreated bacterial, viral or fungal skin infections and should be used with caution in children and on thin skin areas.